Andrew N. Freedman
National Institutes of Health(US)United States Food and Drug Administration(US)National Cancer Institute(US)
Publications by Year
Research Areas
BRCA gene mutations in cancer, Cancer Genomics and Diagnostics, Colorectal Cancer Screening and Detection, Genetic factors in colorectal cancer, Global Cancer Incidence and Screening
Most-Cited Works
- → Revised Bethesda Guidelines for Hereditary Nonpolyposis Colorectal Cancer (Lynch Syndrome) and Microsatellite Instability(2004)3,168 cited
- → Risk of Heart Failure in Breast Cancer Patients After Anthracycline and Trastuzumab Treatment: A Retrospective Cohort Study(2012)556 cited
- → Trends in the use of aspirin and nonsteroidal anti‐inflammatory drugs in the general U.S. population(2013)302 cited
- → Cancer Risk Prediction Models: A Workshop on Development, Evaluation, and Application(2005)271 cited
- → Estimates of the Number of U.S. Women Who Could Benefit From Tamoxifen for Breast Cancer Chemoprevention(2003)260 cited
- → Colorectal Cancer Risk Prediction Tool for White Men and Women Without Known Susceptibility(2008)248 cited